Q4 2021 Fulcrum Therapeutics Inc Earnings Call Transcript
Good morning and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2021 Conference Call. (Operator Instructions)
I would now like to turn the call over to Christi Waarich, Director of Investor Relations at Fulcrum. Please proceed.
Thank you, operator. Good morning and welcome to the Fulcrum Therapeutics conference call. Please be reminded that remarks made during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development timelines and financial projections. While these forward-looking statements represent our views as of today, they should not be relied upon as representing our views in the future. We may update these statements in the future, but we are not taking on an obligation to do so.
Please refer to our most recent filings with the Securities and Exchange Commission for a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |